Coronavirus treatment: 'Encouraging signals' from clinical trial

The preliminary results of a clinical trial suggest a new treatment for Covid-19 reduces the number of patients needing intensive care, according to the UK company that developed it.

Patients were two to three times more likely to recover to the point where everyday activities were not compromised by their illness, Synairgen also says.

Professor Tom Wilkinson, the scientist in charge of the trial, said the results were "encouraging signals" that the drug is having "an important clinical effect".

The results have not been published in a peer-reviewed journal, nor has the full data been made available; so the BBC cannot confirm the claims made for the treatment.

Read more:Coronavirus: Protein treatment trial 'a breakthrough'